COVID paused prevention efforts, which helped fuel the rise in new infections. Now federal funding cuts threaten to disrupt ...

Analysts believe that Gilead's new PrEP drug Yeztugo could reach peak sales of $4.5 billion. Not if GSK has anything to say ...

Acquired immune deficiency syndrome, or AIDS, caused by the human immunodeficiency virus (HIV), weakens the body's immune ...

Discover how understanding your viral load and CD4 count puts you in control of HIV treatment and transforms confusing ...

Increased PrEP usage is linked to decreased HIV diagnosis rates, with a notable decline from 13.0 to 10.6 per 100,000 over a decade. State-level PrEP coverage significantly impacts HIV diagnosis rates ...

The CDC, too, has stepped up its outreach to African American women, said Franciso Ruiz, team leader for national partnerships in the division of HIV/AIDS prevention. Its Pact to Act Against AIDS ...

In the heart of Chicago’s Lakeview neighborhood, the work to shore up healthcare carries on at Howard Brown Health.